You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

List of Excipients in API everolimus tablets

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing everolimus tablets

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC	Excipient
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379	ANHYDROUS LACTOSE
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379	BUTYLATED HYDROXYTOLUENE
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379	CROSPOVIDONE
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379	HYPROMELLOSE
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379	MAGNESIUM STEARATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for everolimus tablets

Excipient focus: ANHYDROUS LACTOSE

everolimus tablets drug variants containing ANHYDROUS LACTOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379
>Company	>Ingredient	>NDC

everolimus tablets drug variants not containing ANHYDROUS LACTOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: BUTYLATED HYDROXYTOLUENE

everolimus tablets drug variants containing BUTYLATED HYDROXYTOLUENE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379
>Company	>Ingredient	>NDC

everolimus tablets drug variants not containing BUTYLATED HYDROXYTOLUENE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

everolimus tablets drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379
>Company	>Ingredient	>NDC

everolimus tablets drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

everolimus tablets drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379
>Company	>Ingredient	>NDC

everolimus tablets drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

everolimus tablets drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Breckenridge Pharmaceutical Inc	everolimus tablets	51991-379
>Company	>Ingredient	>NDC

everolimus tablets drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.